Journal
ENDOCRINE-RELATED CANCER
Volume 17, Issue 3, Pages R161-R172Publisher
BIOSCIENTIFICA LTD
DOI: 10.1677/ERC-10-0071
Keywords
-
Categories
Ask authors/readers for more resources
Adjuvant therapy of differentiated thyroid cancer with radioactive iodine (I-131) is a standard procedure for the ablation of remnant thyroid tissue following surgery and for the treatment of iodine-avid metastases. Presently, there are two dosimetric concepts for the treatment of thyroid cancer using radioiodine: a) the bone marrow dose limited approach and b) lesion-based dosimetry. Both concepts and their clinical applications are described. In addition, the use of I-124 as a diagnostic and dosimetric agent is discussed. Treatment of children and adolescents with radioiodine requires special precautions; individualized approaches in this setting are reviewed. The limitations of treatments aiming at high absorbed doses are addressed as well as the doses to normal organs. Finally, new concepts for further elaborating the potential of thyroid cancer treatment using I-131 are introduced. Endocrine-Related Cancer (2010) 17 R161-R172
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available